Joana Rita Martins Silva

Retrato de Joana Rita Martins Silva
Email: 
joana.m.silva@ipleiria.pt
URI: 
MARE - IPLeiria
Função: 
Investigador
Habilitações: 
Doutoramento
Dominio de investigação: 
Sistemas Costeiros e Oceano
Linhas de investigação: 
Biotecnologia e Valorização dos Recursos
ORCID ID: 
http://orcid.org/0000-0003-1224-1699
Scopus Author ID: 
http://www.scopus.com/authid/detail.uri?authorId=56370819800
Researcher ID: 
http://www.researcherid.com/rid/B-3366-2017
ResearchGate: 
https://www.researchgate.net/profile/Joana_Silva32

Resumo da atividade

Joana Silva (Ph.D) é investigadora contratada no MARE - Politécnico de Leiria, PI do projecto FCT NEURONS4 - New Edge in the therapUtics of PaRkinsON´s diSeaSe from Seaweed (2022.09196.PTDC; orçamento 249K) e co-PI do o projeto NEUROVETOX. Tem atuado na área de biotecnologia marinha com foco na busca de compostos marinhos isolados de macroalgas e seus microrganismos associados com interesse terapêutico na área de farmacologia e dermatologica.

Destaques

Projecto FCT NEURONS4 - New Edge in the therapUtics of PaRkinsON´s diSeaSe from Seaweed (2022.09196.PTDC; orçamento 249K) Neuroprotective and Anti-inflammatory Effects of Rubiscolin-6 Analogs with Proline Surrogates in Position 2 Extraction of macroalgae phenolic compounds for cosmetic application using eutectic solvents Joana Silva, et al., (2021). Loliolide, a New Therapeutic Option for Neurological Diseases? In Vitro Neuroprotective and Anti-Inflammatory Activities of a Monoterpenoid Lactone Isolated from Codium tomentosum. Joana Silva, et al.,. (2021). Disclosing the potential of eleganolone for Parkinson’s disease therapeutics: Neuroprotective and anti-inflammatory activities. Member of the research team in the FCT project “CROSS-ATLANTIC – CReating Opportunities from Seaweed Sulfated polysaccharides for Application in Therapeutics” financiado pela Fundação para a Ciência e a Tecnologia. Budget: 239.898€ (PTDC/BIA-OUT/29250/201 Member of collaborated in Project “POINT4PAC - Precision Oncology by Innovative Therapies and Technologies: 2.4M€ (2017 – 2020). Project NEUROVETOX - NEUROprotective activity of VEnoms and TOXins derived components biosynthesized by fish and dinoflagelates